Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen.
Immunol Cell Biol. 2004 Oct;82(5):539-46. doi: 10.1111/j.0818-9641.2004.01278.x.
Immunol Cell Biol. 2004.
PMID: 15479440